Associate Professor Ilona Faustova is leading our University ‘s partnership effort for a new international master’s programme in Innovative Medicine (IMIM). This will be a big advantage for developing skills in the field and attracting future talent to Tartu, enabling novel scientific and teaching partnerships and collaborations. The courses and modules teach students how to evaluate and improve current technologies and launch start-ups. To achieve this, students receive training in renowned medical and technological innovation centres in Europe, hands-on experience in several research fields, and training in various aspects such as basic science, clinical research, entrepreneurship, market knowledge, clinical innovation, and societal impact.
As the IMIM’s full partner, the Institute of Bioengineering is launching a new master’s study programme. As a hub for the digitalization of bioengineering and incorporation of AI technologies into cell biology, synthetic biology, gas fermentation technologies, and virology, we will offer students unique opportunities to transition from proof-of-concept to prototype in a shorter timeframe than previous standards allowed. This will facilitate the acquisition of interdisciplinary skills and provide extensive practical laboratory experience.
Upon completion of the programme, students are awarded a Double Degree, with graduates making excellent candidates for both PhD and private sector positions.
Importantly, the new programme aligns with DigiBio’s post-project long-term sustainability goals as it prepares a new generation of researchers for the Institute of Bioengineering and regional biotech.